ARTICLE | Company News
CHMP recommends GlaxoSmithKline's Kivexa
September 17, 2004 7:00 AM UTC
The EU's Committee for Medicinal Products for Human Use (CHMP) recommended approval of an MAA for Kivexa abacavir/lamivudine from GlaxoSmithKline (LSE:GSK; GSK) to treat HIV in combination with other ...